METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise against fatty liver cirrhosis
Disease control OngoingThis study tests an experimental drug called efinopegdutide in 80 adults with liver scarring (cirrhosis) caused by a type of fatty liver disease (MASH). The goal is to see if the drug can lower liver fat, inflammation, and scarring over about 7 months. Participants will receive e…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
500 obese patients tracked to unlock secrets of weight loss
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 500 adults with obesity who are trying to lose weight. Researchers collect data on their health, habits, and blood tests to find out what helps or hinders weight loss. The goal is to create personalized weight loss plans based on each person's unique profile.
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 10:50 UTC